Latest Articles

Publication Date
Advanced Endometrial Cancer Pipeline Appears Robust With 25+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - Barchart.com

Advanced Endometrial Cancer Pipeline Appears Robust With 25+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight Barchart.com

Published: May 20, 2025, 11:32 p.m.
MAIPL THERAPEUTICS, INC. FORMS STRATEGIC ALLIANCE WITH ENDOSURE, INC. TO FACILITATE FIRST‑IN‑HUMAN TRIAL OF NOVEL NON‑HORMONAL ENDOMETRIOSIS THERAPY - BioSpace

MAIPL THERAPEUTICS, INC. FORMS STRATEGIC ALLIANCE WITH ENDOSURE, INC. TO FACILITATE FIRST‑IN‑HUMAN TRIAL OF NOVEL NON‑HORMONAL ENDOMETRIOSIS THERAPY BioSpace

Published: May 20, 2025, 12:52 p.m.
MAIPL THERAPEUTICS, INC. FORMS STRATEGIC ALLIANCE WITH ENDOSURE, INC. TO FACILITATE FIRST‑IN‑HUMAN TRIAL OF NOVEL NON‑HORMONAL ENDOMETRIOSIS THERAPY - PR Newswire

MAIPL THERAPEUTICS, INC. FORMS STRATEGIC ALLIANCE WITH ENDOSURE, INC. TO FACILITATE FIRST‑IN‑HUMAN TRIAL OF NOVEL NON‑HORMONAL ENDOMETRIOSIS THERAPY PR Newswire

Published: May 20, 2025, noon
MAIPL THERAPEUTICS, INC. FORMS STRATEGIC ALLIANCE WITH ENDOSURE, INC. TO FACILITATE FIRST‑IN‑HUMAN TRIAL OF NOVEL NON‑HORMONAL ENDOMETRIOSIS THERAPY - Yahoo Finance

MAIPL THERAPEUTICS, INC. FORMS STRATEGIC ALLIANCE WITH ENDOSURE, INC. TO FACILITATE FIRST‑IN‑HUMAN TRIAL OF NOVEL NON‑HORMONAL ENDOMETRIOSIS THERAPY Yahoo Finance

Published: May 20, 2025, noon
Optimistic Outlook for Acrivon Therapeutics: Promising ACR-368 Results and Strategic Focus on Endometrial Cancer - TipRanks

Optimistic Outlook for Acrivon Therapeutics: Promising ACR-368 Results and Strategic Focus on Endometrial Cancer TipRanks

Published: May 15, 2025, 4:53 a.m.
Acrivon Therapeutics Reports First Quarter 2025 Financial Results and Business Highlights - TradingView

Acrivon Therapeutics Reports First Quarter 2025 Financial Results and Business Highlights TradingView

Published: May 14, 2025, 8:10 p.m.
Women's Health Therapeutics Market Poised for Growth: Innovation, Investment and Global Impact - Lelezard

Women's Health Therapeutics Market Poised for Growth: Innovation, Investment and Global Impact Lelezard

Published: May 8, 2025, 7:24 p.m.
These are the HIV therapeutics startups to watch in 2025 - Labiotech.eu

These are the HIV therapeutics startups to watch in 2025 Labiotech.eu

Published: April 16, 2025, 1:04 p.m.
Beyond CRISPR: Brink Therapeutics raises $4 million with engineered recombinases - Labiotech.eu

Beyond CRISPR: Brink Therapeutics raises $4 million with engineered recombinases Labiotech.eu

Published: April 16, 2025, 6:33 a.m.
Acrivon Therapeutics Appoints World-Renowned Oncology Key Opinion Leader and Clinical Investigator Mansoor Raza Mirza, M.D., as Chief Medical Officer - The Manila Times

Acrivon Therapeutics Appoints World-Renowned Oncology Key Opinion Leader and Clinical Investigator Mansoor Raza Mirza, M.D., as Chief Medical Officer The Manila Times

Published: April 7, 2025, 8:16 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!